Piperidin-4-ol → (2-(1H-indazol-4-yl)-4-morpholinothieno[3,2-d]pyrimidin-6-yl)(4-hydroxypiperidin-1-yl)methanone
반응식
[NH:28]1[CH2:29][CH2:30][CH:31]([OH:34])[CH2:32][CH2:33]1.[nH:1]1[n:2][cH:3][c:4]2[c:5](-[c:10]3[n:11][c:12]([N:22]4[CH2:23][CH2:24][O:25][CH2:26][CH2:27]4)[c:13]4[c:14]([n:15]3)[cH:16][c:17]([C:19](=[O:20])[OH:21])[s:18]4)[cH:6][cH:7][cH:8][c:9]12>>[nH:1]1[n:2][cH:3][c:4]2[c:5](-[c:10]3[n:11][c:12]([N:22]4[CH2:23][CH2:24][O:25][CH2:26][CH2:27]4)[c:13]4[c:14]([n:15]3)[cH:16][c:17]([C:19](=[O:20])[N:28]3[CH2:29][CH2:30][CH:31]([OH:34])[CH2:32][CH2:33]3)[s:18]4)[cH:6][cH:7][cH:8][c:9]12참가 물질
3
출처 및 근거
- ORD 기록
- ord-96c8759b51ca48b496bb55c3805c338e
- 출처 데이터셋
- Training data from https://doi.org/10.1039/C8SC04228D (6/10)
반응 노트
불러오는 중…